Client Overview
An international technology company exploring expansion into pharmaceutical manufacturing engaged NGT BioPharma Consultants to provide industry-specific due diligence in support of a potential acquisition of a European modular manufacturing company. The client sought both technical and executive-level insight to assess the target’s readiness, competitiveness, and long-term fit.
The Challenge
The client lacked internal pharmaceutical manufacturing expertise to effectively evaluate the target company’s capabilities and risks.
Needed a comprehensive SWOT analysis covering technology maturity, operational efficiency, and market positioning.
Required an independent assessment of growth potential and future competitiveness to inform acquisition and valuation strategy.
NGT Approach
Conducted extensive research and benchmarking across modular and advanced manufacturing companies in the global pharmaceutical sector.
Applied over 40 years of combined NGT experience in pharmaceutical operations, CMC, and technology development to evaluate the target firm’s technical and business maturity.
Delivered a structured SWOT analysis encompassing: product portfolio, capabilities in biotechnology and small-molecule manufacturing, design and engineering, automation, quality management systems, adaptability to market trends, and scalability potential.
Synthesized findings into a comprehensive due-diligence report highlighting risk areas, growth opportunities, and strategic recommendations.
Outcome / Impact
Delivered a clear, evidence-based evaluation of the acquisition target’s strengths, weaknesses, and market viability.
Provided actionable recommendations that informed the client’s acquisition decision and valuation strategy.
Equipped executives and investors with insight into competitive positioning, pricing dynamics, and profitability outlook, supporting confident, data-driven decision-making.
The client ultimately completed the acquisition and has since expanded their operations beyond Europe, successfully entering and establishing a presence in the U.S. market.